Detalhe da pesquisa
1.
Persistence of monoclonal B-cell expansion and intraclonal diversification despite virus eradication in patients affected by hepatitis C virus-associated lymphoproliferative disorders.
Br J Haematol
; 203(2): 237-243, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37491625
2.
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity.
J Clin Immunol
; 43(4): 680-691, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36795264
3.
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort.
Hepatology
; 76(1): 220-232, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34919289
4.
High prevalence of past hepatitis B virus infection in diffuse large B cell lymphoma: a retrospective study from Italy.
Ann Hematol
; 102(12): 3457-3463, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37650886
5.
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis.
Clin Exp Rheumatol
; 41(4): 787-791, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35894064
6.
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate.
Int J Mol Sci
; 24(14)2023 Jul 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37511357
7.
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases.
J Autoimmun
; 131: 102866, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35841684
8.
Hematological and Genetic Markers in the Rational Approach to Patients With HCV Sustained Virological Response With or Without Persisting Cryoglobulinemic Vasculitis.
Hepatology
; 74(3): 1164-1173, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721342
9.
B-cell activating factor (BAFF), BAFF promoter and BAFF receptor allelic variants in hepatitis C virus related Cryoglobulinemic Vasculitis and Non-Hodgkin's Lymphoma.
Hematol Oncol
; 40(4): 658-666, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35460540
10.
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups.
J Autoimmun
; 125: 102744, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34781162
11.
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression.
Rheumatology (Oxford)
; 60(9): 4418-4427, 2021 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33590837
12.
PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus-related diseases.
Liver Int
; 41(1): 133-149, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32937024
13.
A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disorders.
Genes Immun
; 21(2): 131-135, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32066891
14.
Long-lasting persistence of large B-cell clones in hepatitis C virus-cured patients with complete response of mixed cryoglobulinaemia vasculitis.
Liver Int
; 39(4): 628-632, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30690862
16.
Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2.
Ann Rheum Dis
; 81(3): 441-443, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34819272
18.
Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia.
Hepatology
; 64(5): 1473-1482, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27483451
19.
Long-term effect of HCV eradication in patients with mixed cryoglobulinemia: a prospective, controlled, open-label, cohort study.
Hepatology
; 61(4): 1145-53, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25431357
20.
Assessment of free light chains in HCV-positive patients with mixed cryoglobulinaemia vasculitis undergoing rituximab treatment.
Liver Int
; 35(9): 2100-7, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25800731